Illumina, Inc. develops, manufactures and markets life science tools and integrated systems for the analysis of genetic variation and function.
It provides a comprehensive line of genetic analysis solutions with products and services that serve a broad range of highly interconnected markets, including sequencing, genotyping, gene expression and molecular diagnostics.
Illumina’s goal is to apply innovative sequencing and array technologies to the analysis of genetic variation and function, making studies possible that were not even imaginable just a few years ago.
Illumina’s array-based solutions for genomic analysis serve as tools for disease research, drug discovery, and the development of molecular tests in clinical labs.
Driving healthcare innovation through data and analytics
Legacy Community Health: digitally enabling patient care
Mediterraneo Hospital: Transforming procurement via tech
Cerner Middle East: the journey to healthcare transformation
The Mental Health Center of Denver: The human side of tech
Kettering Health Network’s strategic digital transformation
LTTS: Healthcare tech to navigate the new normal
Northwell Health: Data-driven transformation in healthcare
MED-EL: digital transformation for quality of life
Leumit Health Services: Digital transformation of patient care
How GE Healthcare has harnessed digital technology to transform itself and the world around it
How Allscripts is driving the future of healthcare IT
Diagnostic Services Manitoba: Providing the results that matter
CHRISTUS Health’s digital transformation reimagines healthcare technology and IT
Taiba Hospital: Patient care with promise
Ottawa Hospital: Transforming health care from the inside out
MyHealth Centre: Quality patient experience
American Hospital, Dubai: supporting collaboration within healthcare
How Manipal Health Enterprises has proven that its abilities match its ambitions
Apollo Hospitals: Personalizing healthcare with technology